Multiple Endocrine Neoplasia: Genetics and Clinical Management. Surgical oncology clinics of North America Norton, J. A., Krampitz, G., Jensen, R. T. 2015; 24 (4): 795-832


Early diagnosis of multiple endocrine neoplasia (MEN) syndromes is critical for optimal clinical outcomes; before the MEN syndromes can be diagnosed, they must be suspected. Genetic testing for germline alterations in both the MEN type 1 (MEN1) gene and RET proto-oncogene is crucial to identifying those at risk in affected kindreds and directing timely surveillance and surgical therapy to those at greatest risk of potentially life-threatening neoplasia. Pancreatic, thymic, and bronchial neuroendocrine tumors are the leading cause of death in patients with MEN1 and should be aggressively considered by at least biannual computed tomography imaging.

View details for DOI 10.1016/j.soc.2015.06.008

View details for PubMedID 26363542

View details for PubMedCentralID PMC4571281